Last reviewed · How we verify
Dexmedetomidine hydrochloride Microneedles — Competitive Intelligence Brief
phase 2
Small molecule
Live · refreshed every 30 min
Target snapshot
Dexmedetomidine hydrochloride Microneedles (Dexmedetomidine hydrochloride Microneedles) — Guangzhou Novaken Pharm Co., Ltd..
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Dexmedetomidine hydrochloride Microneedles TARGET | Dexmedetomidine hydrochloride Microneedles | Guangzhou Novaken Pharm Co., Ltd. | phase 2 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Dexmedetomidine hydrochloride Microneedles CI watch — RSS
- Dexmedetomidine hydrochloride Microneedles CI watch — Atom
- Dexmedetomidine hydrochloride Microneedles CI watch — JSON
- Dexmedetomidine hydrochloride Microneedles alone — RSS
Cite this brief
Drug Landscape (2026). Dexmedetomidine hydrochloride Microneedles — Competitive Intelligence Brief. https://druglandscape.com/ci/dexmedetomidine-hydrochloride-microneedles. Accessed 2026-05-18.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab